Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi
Learn more about:
Related Clinical Trial
Experimental Vaccine for Prevention of Ebola Virus Infection
Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)
Phase 1 Trial of Ebola Vaccine in Mali
Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms
Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi
Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever
Treatment of Hemorrhagic Fever With Ribavirin